OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metformin Alters Upper Small Intestinal Microbiota that Impact a Glucose-SGLT1-Sensing Glucoregulatory Pathway
Paige V. Bauer, Frank A. Duca, T.M. Zaved Waise, et al.
Cell Metabolism (2017) Vol. 27, Iss. 1, pp. 101-117.e5
Open Access | Times Cited: 227

Showing 1-25 of 227 citing articles:

Gut Microbiome: Profound Implications for Diet and Disease
Ronald D. Hills, Benjamin Pontefract, Hillary R. Mishcon, et al.
Nutrients (2019) Vol. 11, Iss. 7, pp. 1613-1613
Open Access | Times Cited: 873

Gut microbiota and intestinal FXR mediate the clinical benefits of metformin
Lulu Sun, Cen Xie, Guang Wang, et al.
Nature Medicine (2018) Vol. 24, Iss. 12, pp. 1919-1929
Open Access | Times Cited: 805

Benefits of Metformin in Attenuating the Hallmarks of Aging
Ameya Kulkarni, Sriram Gubbi, Nir Barzilai
Cell Metabolism (2020) Vol. 32, Iss. 1, pp. 15-30
Open Access | Times Cited: 546

Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus
Marc Foretz, Bruno Guigas, Benoı̂t Viollet
Nature Reviews Endocrinology (2019) Vol. 15, Iss. 10, pp. 569-589
Closed Access | Times Cited: 523

The gut microbiota influences anticancer immunosurveillance and general health
Bertrand Routy, Vancheswaran Gopalakrishnan, Romain Daillère, et al.
Nature Reviews Clinical Oncology (2018) Vol. 15, Iss. 6, pp. 382-396
Closed Access | Times Cited: 436

Metformin: update on mechanisms of action and repurposing potential
Marc Foretz, Bruno Guigas, Benoı̂t Viollet
Nature Reviews Endocrinology (2023) Vol. 19, Iss. 8, pp. 460-476
Open Access | Times Cited: 324

The role of the gut microbiome and its metabolites in metabolic diseases
Jiayu Wu, Kai Wang, Xuemei Wang, et al.
Protein & Cell (2020) Vol. 12, Iss. 5, pp. 360-373
Open Access | Times Cited: 321

Metformin: Mechanisms in Human Obesity and Weight Loss
Armen Yerevanian, Alexander A. Soukas
Current Obesity Reports (2019) Vol. 8, Iss. 2, pp. 156-164
Open Access | Times Cited: 305

Metabolic Effects of Dietary Nitrate in Health and Disease
Jon O. Lundberg, Mattias Carlström, Eddie Weitzberg
Cell Metabolism (2018) Vol. 28, Iss. 1, pp. 9-22
Open Access | Times Cited: 303

Host-Microbe-Drug-Nutrient Screen Identifies Bacterial Effectors of Metformin Therapy
Rosina Pryor, Povilas Norvaišas, Γεώργιος Μαρίνος, et al.
Cell (2019) Vol. 178, Iss. 6, pp. 1299-1312.e29
Open Access | Times Cited: 230

Metformin and Autoimmunity: A “New Deal” of an Old Drug
Francesco Ursini, Emilio Russo, Gianluca Pellino, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 182

Metformin: Is it a drug for all reasons and diseases?
Chris R. Triggle, Ibrahim Mohammed, Khalifa Bshesh, et al.
Metabolism (2022) Vol. 133, pp. 155223-155223
Open Access | Times Cited: 182

Role of the gut–brain axis in energy and glucose metabolism
Hallie Wachsmuth, Savanna N. Weninger, Frank A. Duca
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 4, pp. 377-392
Open Access | Times Cited: 129

The metabolic impact of small intestinal nutrient sensing
Frank A. Duca, T.M. Zaved Waise, Willem T. Peppler, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 126

High fat diet, gut microbiome and gastrointestinal cancer
Yao Tong, Huiru Gao, Qiuchen Qi, et al.
Theranostics (2021) Vol. 11, Iss. 12, pp. 5889-5910
Open Access | Times Cited: 126

The Relationship between the Gut Microbiome and Metformin as a Key for Treating Type 2 Diabetes Mellitus
Chae Bin Lee, Soon Uk Chae, Seong Jun Jo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3566-3566
Open Access | Times Cited: 109

Gut Microbiota and Type 2 Diabetes Mellitus: Association, Mechanism, and Translational Applications
Lili Zhang, Jinjin Chu, Wenhao Hao, et al.
Mediators of Inflammation (2021) Vol. 2021, pp. 1-12
Open Access | Times Cited: 105

Metformin and cancer hallmarks: shedding new lights on therapeutic repurposing
Hua Yu, Yue Zheng, Yiran Yao, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 93

Gut Microbiome: Profound Implications for Diet and Disease
Ronald D. Hills, Benjamin Pontefract, Hillary R. Mishcon, et al.
Kompass Nutrition & Dietetics (2022), pp. 1-16
Open Access | Times Cited: 69

Metformin acts in the gut and induces gut-liver crosstalk
Natália Tobar, Guilherme Z. Rocha, Andrey Santos, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 4
Open Access | Times Cited: 43

The emerging role of the small intestinal microbiota in human health and disease
Renate A.A.A. Ruigrok, Rinse K. Weersma, Arnau Vich Vila
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 43

Akkermansia muciniphila protects the intestine from irradiation-induced injury by secretion of propionic acid
Kai-Yue He, Xin‐Yuan Lei, Dan‐Hui Wu, et al.
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 43

Exposure to prescribed medication in early life and impacts on gut microbiota and disease development
Huan Huang, Jiayin Jiang, Xinyu Wang, et al.
EClinicalMedicine (2024) Vol. 68, pp. 102428-102428
Open Access | Times Cited: 20

Cooperative Metabolic Adaptations in the Host Can Favor Asymptomatic Infection and Select for Attenuated Virulence in an Enteric Pathogen
Karina K. Sanchez, Grischa Y. Chen, Alexandria M. Palaferri Schieber, et al.
Cell (2018) Vol. 175, Iss. 1, pp. 146-158.e15
Open Access | Times Cited: 146

Page 1 - Next Page

Scroll to top